2017 Annual Meeting

Session: Diagnostics, Treatments and Theranostics

This session explores the contributions of chemical engineers to the development and commercialization of treatments, diagnostics and theranostics. Contributions from image contrast agents to the design of new medicines welcome.

Chair

Saffari, H., University of Utah

Co-Chair

Zhang, H., University of Utah

Presentations

12:30 PM

(541a) Protein and Gold Nanoparticle Based Radiation Sensor
Thaker, A., Nannenga, B. L., Pushpavanam, K., Rege, K.

12:55 PM

(541b) Direct Detection of Nucleic Acids without Amplification
McGee, Z., Dewberry, S., Wright, C., Koelle, P., Sammon, P., Chittur, K.

01:20 PM

(541c) Photoacoustic Imaging to Simultaneously Detect the Accumulation of Multiple Contrast Agents within Tumors
Wang, L. Z., Lu, H. D., Lim, T. L., Wilson, B. K., Heinmiller, A., Prud'homme, R. K.

01:45 PM

(541d) DNA Methylation Detection with an Engineered Protein That Binds Hemi-Methylated DNA
Sikes, H. D., Tam, B. E., Sung, K. J., Hao, Y., Dabbousi, D. B.

02:10 PM

(541e) Effective Physiological and Anatomical Parameters on Fractional Fluid Reserve (FFR) of Coronary Artery Stenosis
Berson, R. E., Hashemi, J., Ghafghazi, S.

02:35 PM

(541f) Analysis of Carbonyl Compounds in Exhaled Breath for Identificationf of LUNG Cancer Biomarkers
Li, Q., Li, M., Nantz, M. H., Fu, X. A.